Related Experiment Video
Updated: Jun 10, 2026

Examination of Host Phenotypes in Gambusia affinis Following Antibiotic Treatment
Published on: February 22, 2017
Species-specific bioaccumulation and biotransformation of antibiotics shape differential toxicological effects in a
Bin Wang1, Hailing Zhou1, Mengting Li1
1State Key Laboratory of Water Pollution Control and Green Resource Recycling, School of the Environment, Nanjing University, Nanjing 210023, China.
Abstract:
The widespread occurrence of antibiotics in aquatic ecosystems poses a significant ecological threat, yet the mechanisms underlying the differential sensitivity of species remain poorly understood, limiting the accuracy of risk assessments. Here, we investigated the bioaccumulation, biotransformation, and toxicological effects of four typical antibiotics, i.e., sulfamethoxazole (SMX), ciprofloxacin (CIP), oxytetracycline (OTC), and azithromycin (AZM) each at 1, 10, 100 μg/L, in a flow-through freshwater microcosm containing duckweeds, snails, and zebrafish for 45 days. Our results revealed distinct bioaccumulation patterns of antibiotics: duckweeds accumulated the highest levels of the antibiotics facilitated by their ionized form, while accumulation in the animals was governed by hydrophobicity and acid dissociation characteristics. By employing an integrated suspect and non-target screening approach, we identified a total of 33 transformation products (TPs), 18 of which are newly reported. Duckweeds produced the most diverse TP suite, generating unique Phase I (e.g., hydroxylation) and Phase II (e.g., glycosylation and sulfation) TPs, notably including several highly toxic TPs of CIP and OTC. Most of the TPs in the animals were a subset of those observed in duckweeds. These differential bioaccumulation and biotransformation patterns were associated with toxicological outcomes. In duckweeds, oxidative stress correlated with both accumulated parent antibiotics and toxic TPs. Snails displayed minimal physiological effects, while fish experienced oxidative stress from parent antibiotic accumulation and a gut microbiota dysbiosis associated with biomass increase. Our findings elucidate that the species-specific bioaccumulation and biotransformation of antibiotics are key factors shaping differential toxicological effects, providing critical mechanistic insights for refining ecological risk assessment.
More Related Videos
05:46Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
Published on: August 1, 2018
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Drug Distribution: Tissue Binding
For...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Microbiota Modulation by Antibiotics
Toxicity Testing in Animals